DoD Prostate Cancer Dr. Barbara Terry-Koroma Health Disparity Research Award

Quick Facts

Due DateSeptember 24, 2014 (Wednesday)
Award AmountUn-Known
Category of Funding ActivityScience and Technology and other Research and Development
Eligible Applicants
  • Unrestricted (i.e., open to any type of entity below)

Program Description

The PCRP Health Disparity Research Award mechanism was first offered in FY01. Since then, 321 Health Disparity Research Award applications have been received, and 69 have been recommended for funding. The Health Disparity Research Award supports new ideas based on innovative concepts or methodologies for health disparity research with the potential to make an important contribution toward eliminating death from prostate cancer and enhancing the well-being of men impacted by the disease. Studies proposed for this award mechanism are expected to improve the understanding of, and ultimately contribute to eliminating, disparities in prostate cancer incidence, morbidity, mortality, and survivorship. Applicants for this award must explicitly state how the proposed research is related to an area of prostate cancer health disparity. Appropriate health disparity areas include, but are not limited to, race and ethnicity, socioeconomic status, access to or differing standards of health care, insurance status, age, geography, sexual orientation, gender identity, and cultural beliefs. The PCRP seeks applications from investigators from a wide spectrum of disciplines including, but not limited to, basic science, engineering, bioinformatics, population science, translational research, and clinical research, provided they are appropriately focused on an issue of prostate cancer health disparity. In addition, all applications are expected to be relevant to one or more of the PCRP focus areas and are encouraged to be responsive to one of the PCRP overarching challenges. If the proposed project does not address one of the overarching challenges, the application must provide a description to justify how the project will nevertheless address a critical disparity-related need in the field of prostate cancer research and/or patient care. Research involving human subject use is permitted under this funding opportunity, but is restricted to studies without clinical trials; however, correlative studies, including studies with populations from existing clinical trials, are allowed. For definitions and other information on clinical trials and clinical research overall, a Human Subject Resource Document is provided on the eBRAP System at New Investigators: This award encourages applications from investigators in the early stages of their careers. The New Investigator category is designed to allow PIs, early in their faculty appointments or in the process of developing independent research careers, to compete for funding separately from established investigators. Applications from New Investigators and Established Investigators will be peer and programmatically reviewed separately. PIs using the New Investigator category are strongly encouraged to strengthen their applications by including investigators experienced in prostate cancer research and/or possessing other relevant expertise as demonstrated by a record of funding and publications. It is the responsibility of the PI to describe how additional investigators will augment his/her expertise and better address the research question. PIs may choose to employ both the New Investigator category and the Qualified Collaborator Option (described below) in a single application. All applicants for the New Investigator category must meet specific eligibility criteria, as described in Section I.C., Eligibility Information. The Health Disparity Research Award offers two additional options for consideration: 1. Qualified Collaborator Option: The Health Disparity Research Award strongly supports collaborative research involving basic, population science, and clinical researchers, researchers with prostate cancer expertise and those with health disparity expertise, and/or researchers and community organizations that may be critical to the study of populations disproportionately affected by prostate cancer. Although these and other types of collaborations are, in general, strongly encouraged, collaborations that meet specific criteria will qualify for a higher level of funding, as described in Section I.D., Funding. For the application to qualify for a higher level of funding, the PI must submit a Qualified Collaboration Statement that clearly describes the proposed collaborator and collaboration and addresses how each of the criteria below are met. In addition, the collaborator must provide a letter of collaboration describing his/her involvement in the proposed work. It should be clear from both documents that the successful completion of the project depends on the unique skills and contributions of both the PI and the qualified collaborator. The following criteria must be met to use the Qualified Collaborator Option: ? The collaborator must significantly contribute to the project such that the proposed work could not be accomplished without his/her involvement. This is expected to include both intellectual input and research resources (e.g., supplies, reagents, equipment, personnel, services, tissue samples, or access to patients or populations). ? The collaborator must contribute at least a 10% level of effort to the project. Contribution of the collaborator should be reflected in the application budget. ? If the PI does not have experience in prostate cancer research and/or working with disproportionately affected populations, the collaborator must possess such experience. 2. Nested Health Disparity Traineeship Option: This award also offers opportunities for training highly motivated graduate students and postdoctoral fellows interested in pursuing a career in resolving disparities in prostate cancer incidence, morbidity, mortality, and survivorship. The trainee is not required to have previous health disparity or prostate cancer research experience. This option primarily provides salary support for the trainee. An individualized training program in prostate cancer disparities must be described, and may include coursework, laboratory techniques, conferences, seminars, journal clubs, teaching responsibilities, clinical responsibilities, grant writing and/or other activities that will provide the trainee with experience in key areas relevant to the proposed work and foster the trainee's development as a prostate cancer health disparity researcher. An environment appropriate to the proposed training must be clearly described. Only one traineeship (predoctoral or postdoctoral) may be requested per application. Plans for training and mentorship must be well developed and clearly described by the PI in the application.

General Information

Funding Opportunity NumberW81XWH-14-PCRP-HDRA
Funding Opportunity TitleDoD Prostate Cancer Dr. Barbara Terry-Koroma Health Disparity Research Award
Opportunity CategoryScience and Technology and other Research and Development
Funding Instrument TypeCooperative Agreement
Category ExplanationNot Available
Number of Awards6
Cost Sharing or Matching RequirementNo
Posted DateMay 30, 2014 (Friday)
Application Due DateSeptember 24, 2014 (Wednesday)
Application Archive DateOctober 24, 2014 (Friday)
Total Program Funding$ 5,800,000
Award AmountUn-Known
CFDA Number
  • 12.420 - Military Medical Research and Development

Eligible Applicants

  • Unrestricted (i.e., open to any type of entity below)

Contact Information

Agency NameDepartment of Defense
Program Information Website-
ContactOffice: Dept. of the Army -- USAMRAA
CDMRP Help Desk
CDMRP Help Desk

Search Federal Grants

Application Due Date: